We spent over 10 years discovering the hidden power of sound waves to process fluids at the microscale. Utilizing our patented acoustic-based platform and proprietary microparticle technology, we partner with biopharmaceutical companies to advance their biologic formulations beyond current technological limitations. Starting with our partners' new and existing biologics formulations, we create, develop, and manufacture ultra-high concentration, small-volume, low viscosity products, all without the use of solvents or cumbersome post-processing. These ultra-high concentration antibody formulations (HCAFs) uniquely achieve the safety, functionality, stability, and injectability required for subcutaneous administration.

We utilize a patented acoustophoretic technology platform, which combines "acoustic" (relating to sound) and "phoretic" (meaning movement or transport). Hence, our platform uses sound waves to generate microparticles directly in air! These microparticles encapsulate highly concentrated and viscous formulations with exceptional uniformity and control. The consistent size and shape of our microparticles, combined with their ability to flow in a controlled manner, allow them to easily move through narrow openings such as subcutaneous needles. This approach minimizes impact, resulting in virtually zero waste and minimal material loss. Importantly, our platform is largely carrier-independent, enabling us to process the widest range of materials of any available technology. We can handle material viscosities spanning more than four orders of magnitude!